Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T-DM1 Sequential to Anthracycline in Early HER2+ Breast Cancer
NCT01196052Phase 2Completed
- Sponsor
- Roche
- Start
- Oct 2010
- Primary completion
- Jun 2013
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of trastuzumab emtansine in breast cancer, sponsored by Roche. Started Oct 2010; status: completed.
02
Drugs
trastuzumab emtansine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01196052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01196052.